These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38181572)

  • 41. AttentionDTA: Drug-Target Binding Affinity Prediction by Sequence-Based Deep Learning With Attention Mechanism.
    Zhao Q; Duan G; Yang M; Cheng Z; Li Y; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(2):852-863. PubMed ID: 35471889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction.
    Zhang Q; Wei Y; Liao B; Liu L; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2024 Aug; PP():. PubMed ID: 39208057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A survey of drug-target interaction and affinity prediction methods via graph neural networks.
    Zhang Y; Hu Y; Han N; Yang A; Liu X; Cai H
    Comput Biol Med; 2023 Sep; 163():107136. PubMed ID: 37329615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TeM-DTBA: time-efficient drug target binding affinity prediction using multiple modalities with Lasso feature selection.
    Liyaqat T; Ahmad T; Saxena C
    J Comput Aided Mol Des; 2023 Dec; 37(12):573-584. PubMed ID: 37777631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MMFA-DTA: Multimodal Feature Attention Fusion Network for Drug-Target Affinity Prediction for Drug Repurposing Against SARS-CoV-2.
    Chen G; He H; Lv Q; Zhao L; Chen CY
    J Chem Theory Comput; 2024 Sep; ():. PubMed ID: 39269697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Biological Feature and Heterogeneous Network Representation Learning-Based Framework for Drug-Target Interaction Prediction.
    Liu L; Zhang Q; Wei Y; Zhao Q; Liao B
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NG-DTA: Drug-target affinity prediction with n-gram molecular graphs.
    Tsui LI; Hsu TC; Lin C
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DCGAN-DTA: Predicting drug-target binding affinity with deep convolutional generative adversarial networks.
    Kalemati M; Zamani Emani M; Koohi S
    BMC Genomics; 2024 May; 25(1):411. PubMed ID: 38724911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GEFA: Early Fusion Approach in Drug-Target Affinity Prediction.
    Nguyen TM; Nguyen T; Le TM; Tran T
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):718-728. PubMed ID: 34197324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features.
    Pan S; Xia L; Xu L; Li Z
    BMC Bioinformatics; 2023 Sep; 24(1):334. PubMed ID: 37679724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SAG-DTA: Prediction of Drug-Target Affinity Using Self-Attention Graph Network.
    Zhang S; Jiang M; Wang S; Wang X; Wei Z; Li Z
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of drug-target binding affinity based on multi-scale feature fusion.
    Yu H; Xu WX; Tan T; Liu Z; Shi JY
    Comput Biol Med; 2024 Aug; 178():108699. PubMed ID: 38870725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing.
    Abdel-Basset M; Hawash H; Elhoseny M; Chakrabortty RK; Ryan M
    IEEE Access; 2020; 8():170433-170451. PubMed ID: 34786289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TEFDTA: a transformer encoder and fingerprint representation combined prediction method for bonded and non-bonded drug-target affinities.
    Li Z; Ren P; Yang H; Zheng J; Bai F
    Bioinformatics; 2024 Jan; 40(1):. PubMed ID: 38141210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AffinityVAE: A multi-objective model for protein-ligand affinity prediction and drug design.
    Wang M; Li W; Yu X; Luo Y; Han K; Wang C; Jin Q
    Comput Biol Chem; 2023 Dec; 107():107971. PubMed ID: 37852036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring.
    Nguyen TM; Nguyen T; Tran T
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35788823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-Target Binding Affinity Prediction in a Continuous Latent Space Using Variational Autoencoders.
    Zhao L; Zhu Y; Wen N; Wang C; Wang J; Yuan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2024; 21(5):1458-1467. PubMed ID: 38767996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancing generalizability and performance in drug-target interaction identification by integrating pharmacophore and pre-trained models.
    Zhang Z; He X; Long D; Luo G; Chen S
    Bioinformatics; 2024 Jun; 40(Suppl 1):i539-i547. PubMed ID: 38940179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling DTA by Combining Multiple-Instance Learning with a Private-Public Mechanism.
    Wang C; Chen Y; Zhao L; Wang J; Wen N
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MFR-DTA: a multi-functional and robust model for predicting drug-target binding affinity and region.
    Hua Y; Song X; Feng Z; Wu X
    Bioinformatics; 2023 Feb; 39(2):. PubMed ID: 36708000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.